Prognostic Value of


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 02 2023
Historique:
pubmed: 1 11 2022
medline: 1 2 2023
entrez: 31 10 2022
Statut: ppublish

Résumé

The applicability of In 161 patients with de novo NGS-based NGS-based detection of

Identifiants

pubmed: 36315929
doi: 10.1200/JCO.22.00715
pmc: PMC9901965
doi:

Substances chimiques

Nuclear Proteins 0
fms-Like Tyrosine Kinase 3 EC 2.7.10.1
FLT3 protein, human EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-765

Références

Cell. 2012 Jul 20;150(2):264-78
pubmed: 22817890
Sci Transl Med. 2012 Aug 29;4(149):149ra118
pubmed: 22932223
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2548-53
pubmed: 24550281
Blood. 2007 Feb 15;109(4):1643-52
pubmed: 17047150
Blood Adv. 2021 Feb 23;5(4):1110-1121
pubmed: 33616652
Blood. 2021 Jun 3;137(22):3093-3104
pubmed: 33598693
Blood. 2012 Jun 7;119(23):5367-73
pubmed: 22422824
Blood. 2017 Mar 23;129(12):1636-1645
pubmed: 28049642
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Genes Chromosomes Cancer. 2012 Jul;51(7):689-95
pubmed: 22454318
Blood Adv. 2018 Apr 24;2(8):825-831
pubmed: 29643105
Blood. 2013 Jul 4;122(1):100-8
pubmed: 23704090
Cancer Discov. 2019 Aug;9(8):1050-1063
pubmed: 31088841
Leukemia. 2019 Feb;33(2):299-312
pubmed: 30651634
N Engl J Med. 2018 Mar 29;378(13):1189-1199
pubmed: 29601269
Blood. 2021 Dec 30;138(26):2753-2767
pubmed: 34724563
Blood. 2002 Oct 1;100(7):2393-8
pubmed: 12239147
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Cancers (Basel). 2021 Oct 29;13(21):
pubmed: 34771594
Blood. 2015 Nov 26;126(22):2491-501
pubmed: 26438511
Leukemia. 2019 Oct;33(10):2535-2539
pubmed: 31089248
N Engl J Med. 2017 Aug 3;377(5):454-464
pubmed: 28644114
Blood. 2002 Oct 1;100(7):2387-92
pubmed: 12239146

Auteurs

Tim Grob (T)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Mathijs A Sanders (MA)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Christian M Vonk (CM)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Franҫois G Kavelaars (FG)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Melissa Rijken (M)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Diana W Hanekamp (DW)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Patrycja L Gradowska (PL)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Jacqueline Cloos (J)

Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Yngvar Fløisand (Y)

Department of Hematology, Oslo University Hospital, Oslo, Norway.

Marinus van Marwijk Kooy (M)

Department of Hematology, Isala Hospital, Zwolle, the Netherlands.

Markus G Manz (MG)

Department of Medical Oncology and Hematology, Comprehensive Cancer Center Zurich, University Hospital Zurich, Zurich, Switzerland.

Gert J Ossenkoppele (GJ)

Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Lidwine W Tick (LW)

Department of Hematology, Maxima Medisch Centrum, Eindhoven, the Netherlands.

Violaine Havelange (V)

Department of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium.

Bob Löwenberg (B)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Mojca Jongen-Lavrencic (M)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Peter J M Valk (PJM)

Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH